Found: 196
Select item for more details and to access through your institution.
Association Between Environmental Tobacco Smoke Exposure and the Occurrence of EGFR Mutations and ALK Rearrangements in Never-smokers With Non-Small-cell Lung Cancer: Analyses From a Prospective Multinational ETS Registry.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Biomarker-driven phase 2 umbrella trial study for patients with recurrent small cell lung cancer failing platinum-based chemotherapy.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Genomic landscape of acquired resistance to third-generation EGFR tyrosine kinase inhibitors in EGFR T790M-mutant non-small cell lung cancer.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Osimertinib in patients with T790M mutation-positive, advanced non-small cell lung cancer: Long-term follow-up from a pooled analysis of 2 phase 2 studies.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Volume-based growth tumor kinetics as a prognostic biomarker for patients with EGFR mutant lung adenocarcinoma undergoing EGFR tyrosine kinase inhibitor therapy: a case control study.
- Published in:
- 2016
- By:
- Publication type:
- journal article
ERK inhibitor ASN007 effectively overcomes acquired resistance to EGFR inhibitor in non‐small cell lung cancer.
- Published in:
- Investigational New Drugs, 2022, v. 40, n. 2, p. 265, doi. 10.1007/s10637-021-01121-6
- By:
- Publication type:
- Article
Entrectinib resistance mechanisms in ROS1-rearranged non-small cell lung cancer.
- Published in:
- Investigational New Drugs, 2020, v. 38, n. 2, p. 360, doi. 10.1007/s10637-019-00795-3
- By:
- Publication type:
- Article
Phase I trial and pharmacokinetic study of tanibirumab, a fully human monoclonal antibody to vascular endothelial growth factor receptor 2, in patients with refractory solid tumors.
- Published in:
- Investigational New Drugs, 2017, v. 35, n. 6, p. 782, doi. 10.1007/s10637-017-0463-y
- By:
- Publication type:
- Article
AZD9291 overcomes T790 M-mediated resistance through degradation of EGFR in non-small cell lung cancer cells.
- Published in:
- Investigational New Drugs, 2016, v. 34, n. 4, p. 407, doi. 10.1007/s10637-016-0350-y
- By:
- Publication type:
- Article
BYL719, a selective inhibitor of phosphoinositide 3-Kinase α, enhances the effect of selumetinib (AZD6244, ARRY-142886) in KRAS-mutant non-small cell lung cancer.
- Published in:
- 2015
- By:
- Publication type:
- Journal Article
BYL719, a selective inhibitor of phosphoinositide 3-Kinase α, enhances the effect of selumetinib (AZD6244, ARRY-142886) in KRAS-mutant non-small cell lung cancer.
- Published in:
- Investigational New Drugs, 2015, v. 33, n. 1, p. 12, doi. 10.1007/s10637-014-0163-9
- By:
- Publication type:
- Article
Salvage chemotherapy with mitomycin C, ifosfamide, and cisplatin (MIC) for previously treated metastatic or recurrent esophageal squamous cell carcinoma.
- Published in:
- Investigational New Drugs, 2008, v. 26, n. 4, p. 387, doi. 10.1007/s10637-008-9126-3
- By:
- Publication type:
- Article
Outcome and predictors of mortality in patients requiring invasive mechanical ventilation due to acute respiratory failure while undergoing ambulatory chemotherapy for solid cancers.
- Published in:
- Supportive Care in Cancer, 2013, v. 21, n. 6, p. 1647, doi. 10.1007/s00520-012-1709-z
- By:
- Publication type:
- Article
Phospho-Stat3 expression and correlation with VEGF, p53, and Bcl-2 in gastric carcinoma using tissue microarray.
- Published in:
- APMIS, 2006, v. 114, n. 9, p. 619, doi. 10.1111/j.1600-0463.2006.apm_401.x
- By:
- Publication type:
- Article
Exome sequencing reveals recurrent REV3L mutations in cisplatin-resistant squamous cell carcinoma of head and neck.
- Published in:
- Scientific Reports, 2016, p. 19552, doi. 10.1038/srep19552
- By:
- Publication type:
- Article
Lazertinib versus Gefitinib as First-Line Treatment for EGFR-Mutated Locally Advanced or Metastatic NSCLC: LASER301 Korean Subset.
- Published in:
- Cancer Research & Treatment, 2024, v. 56, n. 1, p. 48, doi. 10.4143/crt.2023.453
- By:
- Publication type:
- Article
First-Line Alectinib vs. Brigatinib in Advanced Non-Small Cell Lung Cancer with ALK Rearrangement: Real-World Data.
- Published in:
- Cancer Research & Treatment, 2024, v. 56, n. 1, p. 61, doi. 10.4143/crt.2023.461
- By:
- Publication type:
- Article
A Phase II Trial of Nintedanib in Patients with Metastatic or Recurrent Head and Neck Squamous Cell Carcinoma: In-Depth Analysis of Nintedanib Arm from the KCSG HN 15-16 TRIUMPH Trial.
- Published in:
- Cancer Research & Treatment, 2024, v. 56, n. 1, p. 37, doi. 10.4143/crt.2023.433
- By:
- Publication type:
- Article
Expanded Access Program Pralsetinib in Advanced Non-Small Cell Lung Cancer with Rearranged during Transfection (RET) Gene Rearrangement.
- Published in:
- Cancer Research & Treatment, 2023, v. 55, n. 4, p. 1144, doi. 10.4143/crt.2023.403
- By:
- Publication type:
- Article
Phase II Trial of Combined Durvalumab Plus Tremelimumab with Proton Therapy for Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma.
- Published in:
- Cancer Research & Treatment, 2023, v. 55, n. 4, p. 1104, doi. 10.4143/crt.2023.502
- By:
- Publication type:
- Article
EGFR Mutation-Positive Unresectable Stage III Non-Squamous Lung Cancer Is Associated with a High Incidence of Brain Metastasis.
- Published in:
- Cancer Research & Treatment, 2023, v. 55, n. 2, p. 498, doi. 10.4143/crt.2022.388
- By:
- Publication type:
- Article
The Role of Brain Radiotherapy before First-Line Afatinib Therapy, Compared to Gefitinib or Erlotinib, in Patients with EGFR-Mutant Non-Small Cell Lung Cancer.
- Published in:
- Cancer Research & Treatment, 2023, v. 55, n. 2, p. 479, doi. 10.4143/crt.2022.1344
- By:
- Publication type:
- Article
Osimertinib Combined with Systemic Chemotherapy for EGFR Mutant, T790M-Negative, Non–Small Cell Lung Cancer Patients Who Develop Leptomeningeal Metastases with Extracranial Progression to Prior EGFR TKI.
- Published in:
- Cancer Research & Treatment, 2023, v. 55, n. 1, p. 344, doi. 10.4143/crt.2021.1603
- By:
- Publication type:
- Article
A Single-Arm, Prospective, Phase II Study of Cisplatin Plus Weekly Docetaxel as First-Line Therapy in Patients with Metastatic or Recurrent Salivary Gland Cancer.
- Published in:
- Cancer Research & Treatment, 2022, v. 54, n. 3, p. 719, doi. 10.4143/crt.2021.1019
- By:
- Publication type:
- Article
The Impact of EGFR Tyrosine Kinase Inhibitor on the Natural Course of Concurrent Subsolid Nodules in Patients with Non–Small Cell Lung Cancer.
- Published in:
- Cancer Research & Treatment, 2022, v. 54, n. 3, p. 817, doi. 10.4143/crt.2021.822
- By:
- Publication type:
- Article
Long-term Survival in Non-Small Cell Lung Cancer Patients with Metachronous Brain-Only Oligorecurrence Who Underwent Definitive Treatment.
- Published in:
- Cancer Research & Treatment, 2022, v. 54, n. 1, p. 150, doi. 10.4143/crt.2021.306
- By:
- Publication type:
- Article
Outcomes and Biomarkers of Immune Checkpoint Inhibitor Therapy in Patients with Refractory Head and Neck Squamous Cell Carcinoma: KCSG HN18-12.
- Published in:
- Cancer Research & Treatment, 2021, v. 53, n. 3, p. 671, doi. 10.4143/crt.2020.824
- By:
- Publication type:
- Article
EGFR C797S as a Resistance Mechanism of Lazertinib in Non-small Cell Lung Cancer with EGFR T790M Mutation.
- Published in:
- Cancer Research & Treatment, 2020, v. 52, n. 4, p. 1288, doi. 10.4143/crt.2020.278
- By:
- Publication type:
- Article
Real-World Experience of Nivolumab in Non-small Cell Lung Cancer in Korea.
- Published in:
- Cancer Research & Treatment, 2020, v. 52, n. 4, p. 1112, doi. 10.4143/crt.2020.245
- By:
- Publication type:
- Article
Clinical Characteristics and Outcomes of Non-small Cell Lung Cancer Patients with HER2 Alterations in Korea.
- Published in:
- Cancer Research & Treatment, 2020, v. 52, n. 1, p. 292, doi. 10.4143/crt.2019.186
- By:
- Publication type:
- Article
Osimertinib in Patients with T790M-Positive Advanced Non-small Cell Lung Cancer: Korean Subgroup Analysis from Phase II Studies.
- Published in:
- Cancer Research & Treatment, 2020, v. 52, n. 1, p. 284, doi. 10.4143/crt.2019.200
- By:
- Publication type:
- Article
Clinical Outcomes of EGFR Exon 20 Insertion Mutations in Advanced Non-small Cell Lung Cancer in Korea.
- Published in:
- Cancer Research & Treatment, 2019, v. 51, n. 2, p. 623, doi. 10.4143/crt.2018.151
- By:
- Publication type:
- Article
Efficacy and Safety of Afatinib for EGFR-mutant Non-small Cell Lung Cancer, Compared with Gefitinib or Erlotinib.
- Published in:
- Cancer Research & Treatment, 2019, v. 51, n. 2, p. 502, doi. 10.4143/crt.2018.117
- By:
- Publication type:
- Article
EGFR Mutation Is Associated with Short Progression-Free Survival in Patients with Stage III Non-squamous Cell Lung Cancer Treated with Concurrent Chemoradiotherapy.
- Published in:
- Cancer Research & Treatment, 2019, v. 51, n. 2, p. 493, doi. 10.4143/crt.2018.125
- By:
- Publication type:
- Article
Investigating the Feasibility of Targeted Next-Generation Sequencing to Guide the Treatment of Head and Neck Squamous Cell Carcinoma.
- Published in:
- Cancer Research & Treatment, 2019, v. 51, n. 1, p. 300, doi. 10.4143/crt.2018.012
- By:
- Publication type:
- Article
Rare Mechanism of Acquired Resistance to Osimertinib in Korean Patients with EGFR-Mutated Non-small Cell Lung Cancer.
- Published in:
- Cancer Research & Treatment, 2019, v. 51, n. 1, p. 408, doi. 10.4143/crt.2018.138
- By:
- Publication type:
- Article
Role of Adjuvant Thoracic Radiation Therapy and Full Dose Chemotherapy in pN2 Non-small Cell Lung Cancer: Elucidation Based on Single Institute Experience.
- Published in:
- Cancer Research & Treatment, 2017, v. 49, n. 4, p. 880, doi. 10.4143/crt.2016.442
- By:
- Publication type:
- Article
Efficacy and Safety of First-Line Necitumumab Plus Gemcitabine and Cisplatin Versus Gemcitabine and Cisplatin in East Asian Patients with Stage IV Squamous Non-small Cell Lung Cancer: A Subgroup Analysis of the Phase 3, Open-Label, Randomized SQUIRE Study
- Published in:
- Cancer Research & Treatment, 2017, v. 49, n. 4, p. 937, doi. 10.4143/crt.2016.423
- By:
- Publication type:
- Article
Genetic Alterations and Their Clinical Implications in High-Recurrence Risk Papillary Thyroid Cancer.
- Published in:
- Cancer Research & Treatment, 2017, v. 49, n. 4, p. 906, doi. 10.4143/crt.2016.424
- By:
- Publication type:
- Article
Association between PD-L1 and HPV Status and the Prognostic Value of PD-L1 in Oropharyngeal Squamous Cell Carcinoma.
- Published in:
- Cancer Research & Treatment, 2016, v. 48, n. 2, p. 527, doi. 10.4143/crt.2015.249
- By:
- Publication type:
- Article
Tolerability and Outcomes of First-Line Pemetrexed-Cisplatin Followed by Gefitinib Maintenance Therapy Versus Gefitinib Monotherapy in Korean Patients with Advanced Nonsquamous Non-small Cell Lung Cancer: A Post Hoc Descriptive Subgroup Analysis of a Randomized, Phase 3 Trial
- Published in:
- Cancer Research & Treatment, 2016, v. 48, n. 2, p. 458, doi. 10.4143/crt.2015.135
- By:
- Publication type:
- Article
Current Status and Challenges of Cancer Clinical Trials in Korea.
- Published in:
- Cancer Research & Treatment, 2016, v. 48, n. 1, p. 20, doi. 10.4143/crt.2014.317
- By:
- Publication type:
- Article
Definitive Bimodality Concurrent Chemoradiotherapy in Patients with Inoperable N2-positive Stage IIIA Non-small Cell Lung Cancer.
- Published in:
- Cancer Research & Treatment, 2015, v. 47, n. 4, p. 645, doi. 10.4143/crt.2014.144
- By:
- Publication type:
- Article
Pemetrexed Continuation Maintenance in Patients with Nonsquamous Non-small Cell Lung Cancer: Review of Two East Asian Trials in Reference to PARAMOUNT.
- Published in:
- Cancer Research & Treatment, 2015, v. 47, n. 3, p. 424, doi. 10.4143/crt.2013.266
- By:
- Publication type:
- Article
Tumor Lysis Syndrome in a Solid Tumor: A Case Report of a Patient with Invasive Thymoma.
- Published in:
- 2013
- By:
- Publication type:
- Case Study
Acquired resistance to AZD9291 as an upfront treatment is dependent on ERK signaling in a preclinical model.
- Published in:
- PLoS ONE, 2018, v. 13, n. 4, p. 1, doi. 10.1371/journal.pone.0194730
- By:
- Publication type:
- Article
Phase I Trial of Anti-MET Monoclonal Antibody in MET-Overexpressed Refractory Cancer.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Dual-Energy CT in Patients Treated with Anti-Angiogenic Agents for Non-Small Cell Lung Cancer: New Method of Monitoring Tumor Response?
- Published in:
- Korean Journal of Radiology, 2012, v. 13, n. 6, p. 702, doi. 10.3348/kjr.2012.13.6.702
- By:
- Publication type:
- Article
Acute erythroleukemia in a rheumatoid arthritis patient during low-dose methotrexate therapy.
- Published in:
- Rheumatology International, 2005, v. 25, n. 4, p. 311, doi. 10.1007/s00296-004-0502-9
- By:
- Publication type:
- Article
Prognostic Impact of Longitudinal Monitoring of Radiomic Features in Patients with Advanced Non-Small Cell Lung Cancer.
- Published in:
- Scientific Reports, 2019, v. 9, n. 1, p. N.PAG, doi. 10.1038/s41598-019-45117-y
- By:
- Publication type:
- Article